375 related articles for article (PubMed ID: 18457323)
1. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
Cho CS; Labow DM; Tang L; Klimstra DS; Loeffler AG; Leverson GE; Fong Y; Jarnagin WR; D'Angelica MI; Weber SM; Blumgart LH; Dematteo RP
Cancer; 2008 Jul; 113(1):126-34. PubMed ID: 18457323
[TBL] [Abstract][Full Text] [Related]
2. Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach.
Saxena A; Chua TC; Sarkar A; Chu F; Liauw W; Zhao J; Morris DL
Surgery; 2011 Feb; 149(2):209-20. PubMed ID: 20674950
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
4. Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.
Reddy SK; Barbas AS; Marroquin CE; Morse MA; Kuo PC; Clary BM
J Am Coll Surg; 2007 Mar; 204(3):372-82. PubMed ID: 17324770
[TBL] [Abstract][Full Text] [Related]
5. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
Saxena A; Chua TC; Zhao J; Morris DL
J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
[TBL] [Abstract][Full Text] [Related]
6. Optimizing the surgical effort in patients with advanced neuroendocrine neoplasm hepatic metastases: a critical analysis of 40 patients treated by hepatic resection and cryoablation.
Saxena A; Chua TC; Chu F; Al-Zahrani A; Morris DL
Am J Clin Oncol; 2012 Oct; 35(5):439-45. PubMed ID: 21654315
[TBL] [Abstract][Full Text] [Related]
7. Surgery for hepatic neuroendocrine tumors: a single institutional experience in Japan.
Hibi T; Sano T; Sakamoto Y; Takahashi Y; Uemura N; Ojima H; Shimada K; Kosuge T
Jpn J Clin Oncol; 2007 Feb; 37(2):102-7. PubMed ID: 17234654
[TBL] [Abstract][Full Text] [Related]
8. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
[TBL] [Abstract][Full Text] [Related]
9. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
Teh SH; Deveney C; Sheppard BC
Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
[TBL] [Abstract][Full Text] [Related]
10. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer.
Ito H; Are C; Gonen M; D'Angelica M; Dematteo RP; Kemeny NE; Fong Y; Blumgart LH; Jarnagin WR
Ann Surg; 2008 Jun; 247(6):994-1002. PubMed ID: 18520227
[TBL] [Abstract][Full Text] [Related]
11. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
12. Metastectomy for non-colorectal, non-neuroendocrine liver secondaries.
Teo MC; Tan YM; Chung AY; Chow PK; Cheow PC; Soo KC; Hee SW; Ooi LL
ANZ J Surg; 2006 Jul; 76(7):575-8. PubMed ID: 16813621
[TBL] [Abstract][Full Text] [Related]
13. Predictors of survival after resection of early hepatocellular carcinoma.
Nathan H; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
[TBL] [Abstract][Full Text] [Related]
14. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
15. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
16. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.
Yao KA; Talamonti MS; Nemcek A; Angelos P; Chrisman H; Skarda J; Benson AB; Rao S; Joehl RJ
Surgery; 2001 Oct; 130(4):677-82; discussion 682-5. PubMed ID: 11602899
[TBL] [Abstract][Full Text] [Related]
17. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.
Bilimoria KY; Talamonti MS; Tomlinson JS; Stewart AK; Winchester DP; Ko CY; Bentrem DJ
Ann Surg; 2008 Mar; 247(3):490-500. PubMed ID: 18376195
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.
Sarmiento JM; Heywood G; Rubin J; Ilstrup DM; Nagorney DM; Que FG
J Am Coll Surg; 2003 Jul; 197(1):29-37. PubMed ID: 12831921
[TBL] [Abstract][Full Text] [Related]
19. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
[TBL] [Abstract][Full Text] [Related]
20. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]